Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Manager, Global Regulatory Affairs Project Management is an integral part of the global Regulatory Affairs organization and is responsible for translating complex global regulatory strategies into actionable execution plans, in partnership with and reporting to a Director, Global Regulatory Affairs Project Management. This role applies strong project management expertise and operational leadership to drive cross-functional planning, coordination, and execution of planned and ongoing regulatory activities, across RevMed programs. The ideal candidate will have a solid understanding of drug development (with oncology experience) and demonstrated hands-on regulatory project management experience supporting early- and/or late-stage development programs, including healthy authority submissions and interactions, in alignment with corporate objectives.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level